ATE334207T1 - CELL CYCLE CHECKPOINT-SPECIFIC GENES - Google Patents

CELL CYCLE CHECKPOINT-SPECIFIC GENES

Info

Publication number
ATE334207T1
ATE334207T1 AT96929433T AT96929433T ATE334207T1 AT E334207 T1 ATE334207 T1 AT E334207T1 AT 96929433 T AT96929433 T AT 96929433T AT 96929433 T AT96929433 T AT 96929433T AT E334207 T1 ATE334207 T1 AT E334207T1
Authority
AT
Austria
Prior art keywords
cell cycle
specific genes
cycle checkpoint
relates
polypeptide products
Prior art date
Application number
AT96929433T
Other languages
German (de)
Inventor
Antony Michael Carr
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9518220.0A external-priority patent/GB9518220D0/en
Application filed by Icos Corp filed Critical Icos Corp
Application granted granted Critical
Publication of ATE334207T1 publication Critical patent/ATE334207T1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

This invention relates to a class of checkpoint genes and their polypeptide products which control progression through the cell cycle in eukaryotic cells. In particular this invention relates to Schizosaccharomyces pombe rad3 gene, to its human homologue (ATR) and to their encoded proteins. The invention further relates to assay methods for selecting compounds which modulate the activity of the polypeptide products of these checkpoint genes and the use of the selected compounds in anticancer therapy.
AT96929433T 1995-09-06 1996-09-06 CELL CYCLE CHECKPOINT-SPECIFIC GENES ATE334207T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9518220.0A GB9518220D0 (en) 1995-09-06 1995-09-06 Checkpoint gene

Publications (1)

Publication Number Publication Date
ATE334207T1 true ATE334207T1 (en) 2006-08-15

Family

ID=35820841

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96929433T ATE334207T1 (en) 1995-09-06 1996-09-06 CELL CYCLE CHECKPOINT-SPECIFIC GENES

Country Status (3)

Country Link
AT (1) ATE334207T1 (en)
DE (1) DE69636391D1 (en)
RU (2) RU2252256C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2671974C2 (en) * 2013-03-05 2018-11-08 Ф. Хоффманн-Ля Рош Аг Method and system for determining biological response of target to soluble candidate substance

Also Published As

Publication number Publication date
RU2252256C2 (en) 2005-05-20
DE69636391D1 (en) 2006-09-07
RU2004139232A (en) 2006-06-10
MX9801699A (en) 1998-10-31

Similar Documents

Publication Publication Date Title
FR17C1046I2 (en) NEW B7-4 MOLECULES AND THEIR USES
DE69635931D1 (en) COMPLEMENTARY ADENOVIRENVEKTORSYSTEME AND CELL LINES
MX9800719A (en) Transport proteins and their uses.
MX9705039A (en) Programmed cell death genes and proteins.
IL117425A0 (en) Receptor activation by gas6
TW428026B (en) Bifunctional protein, preparation and use
AU560340B2 (en) Rennin from recombinant dna
DE69233478T8 (en) NEW HUMAN CDC25 GENES, ENCODED PRODUCTS AND THEIR USE
CY1108459T1 (en) AKT-3 NUCLEAR ACIDS, POLYPALPTESES, AND THEIR USES
CA2285667A1 (en) Viral vectors having chimeric envelope proteins containing the igg-binding domain of protein a
MX9801264A (en) Control of cd44 gene expression for therapeutic use.
ATE391175T1 (en) MULTIDRUG RESISTANCE GENE
WO1997018323A3 (en) Cell-cycle checkpoint phosphatidylinositol- (pik-) related kinases, genes coding therefor and methods for assaying and modulating enzymatic activity
NO972063L (en) Isolated BMP receptor kinase protein, DNA sequence, recombinant expression vector and host cell
ATE334207T1 (en) CELL CYCLE CHECKPOINT-SPECIFIC GENES
HK1002284A1 (en) Novel implant and novel vector for the treatment of acquired diseases
DK0745122T3 (en) Galnin receptor, nucleic acids, transformed cells and uses thereof
ATE364706T1 (en) NUCLEOTIDE AND PROTEIN SEQUENCE OF MAMMASTATIN AND METHODS OF APPLICATION
ATE294862T1 (en) HUMAN SEL-10 POLYPEPTIDES AND POLYNUCLEOTIDES CODING THEREOF
WO1999018203A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS
DE69837808D1 (en) pRb2 / p130 PEPTIDINHIBITORS OF cdk2 KINASEACTIVITY
WO2002014369A3 (en) Human kininogen d5 domain polypeptides and their use
BR9407357A (en) New tripeptides usable in cns and immune therapy
WO1999018202A3 (en) HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND cDNAs ENCODING THESE PROTEINS
BR9911211A (en) Method for inducing apoptosis in cells

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties